Sign in
4

Changes in Ownership

IONIS PHARMACEUTICALS INC Filed Acc 0000874015-25-000170

Chief Executive Officer sold 2,432 shares at $45.00 ($109,440)

  • Chief Executive Officer acquired 2,432 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Monia Brett P · Chief Executive Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-07-30 Exercise or conversion : show line 1 in the form 10b5-1 +2,432 $32.60 $79,283 182,252 D
2025-07-30 Sale : show line 2 in the form 10b5-1 −2,432 $45.00 $109,440 179,820 D
Open-market sales · 2,432 sh · avg $45.00 · $109,440

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-07-30 Exercise or conversion : show line 3 in the form 10b5-1 Non-Qualified Stock Option (right to buy) −2,432 99,057 D
Loading xslF345X05/edgardoc.xml…